Top compounds associated with response to USP17L22


Feature Type Standardized
Nominal ANOVA
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.012 0.7
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.011 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
mRNA PF-750 CTRPv2 pan-cancer AAC -0.012 0.8
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.0088 0.8
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC 0.044 0.8
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC -0.015 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
Download CSV